Advertisement
Advertisement
Gilead Sciences, Inc. (GILD)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Follow
As of 10:34AM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Performance Outlook
| Previous Close | 75.42 |
| Open | 75.51 |
| Bid | 75.58 x 900 |
| Ask | 75.58 x 800 |
| Day's Range | 75.21 - 75.68 |
| 52 Week Range | 61.45 - 89.74 |
| Volume | |
| Avg. Volume | 5,471,366 |
| Market Cap | 93.987B |
| Beta (5Y Monthly) | 0.39 |
| PE Ratio (TTM) | 17.34 |
| EPS (TTM) | 4.35 |
| Earnings Date | Oct 25, 2023 - Oct 30, 2023 |
| Forward Dividend & Yield | 3.00 (3.98%) |
| Ex-Dividend Date | Sep 14, 2023 |
| 1y Target Est | 91.04 |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
41% Est. Return
Subscribe to Yahoo Finance Plus to view Fair Value for GILD
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
- Gilead Sciences, Inc.Analyst Report: Gilead Sciences, Inc.Gilead Sciences is a biopharmaceutical company that researches, develops, and sells therapies for treating HIV, hepatitis B, hepatitis C, and certain cancers. In October 2020, Gilead's Veklury (remdesivir) became the first approved treatment for COVID-19 in the U.S. Founded in 1987, the company is located in Foster City, California. It has operations in more than 35 countries and approximately 17,000 employees.RatingFair ValueEconomic Moat11 days agoArgus Research
Simply Wall St.Here's Why We Think Gilead Sciences (NASDAQ:GILD) Might Deserve Your Attention Today
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
ZacksGilead Sciences (GILD) Gains As Market Dips: What You Should Know
Gilead Sciences (GILD) closed the most recent trading day at $75.53, moving +0.94% from the previous trading session.
GuruFocus.comUnveiling Gilead Sciences (GILD)'s Value: Is It Really Priced Right? A Comprehensive Guide
An in-depth analysis of Gilead Sciences' intrinsic value, financial strength, profitability, and growth
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2023 Yahoo. All rights reserved.
